Research and Data Methodology | TRT Provider Guide

What This Methodology Covers

This methodology applies to research and data used in:

TRT educational guides
Provider reviews and comparisons
Cost tables and first-year cost estimates
Treatment-format comparisons
Testing, fertility, safety, and monitoring guides
State availability and telehealth information
Provider rating inputs
Calculators, worksheets, and decision tools
Summaries of clinical studies, guidelines, and regulatory actions
Original tables or datasets compiled from public information

This page governs how information is found, classified, calculated, and maintained.

Our Editorial Standards explain how we write and cite content. Our provider-review methodology explains how individual clinics are evaluated. Our TRT Provider Rating Methodology explains how eligible research fields are converted into ratings. Our Medical Review Policy explains when a page may carry a medical-review label.

Unless a page clearly states otherwise, TRT Provider Guide focuses on educational information for adults in the United States who are investigating testosterone deficiency and medically supervised testosterone care. Our content is not designed to guide pediatric treatment, athletic-performance enhancement, bodybuilding drug use, or nonmedical use of testosterone or other anabolic steroids.

Who Is Responsible for Our Content

Pages that do not identify a real individual contributor use the organization-level byline “TRT Provider Guide.”

That byline identifies the publisher responsible for the content. It does not imply that a physician wrote the page, that a licensed clinician reviewed it, or that the site has a particular number of employees.

We do not:

Create fictional authors, editors, researchers, or medical reviewers
Invent professional biographies, degrees, licenses, or clinical experience
Attribute content to someone who did not contribute to it
Use an “editorial team” byline to imply personnel or credentials that have not been publicly established
Treat a list of medical citations as equivalent to review by a licensed clinician

When a real individual contributor or reviewer is identified in the future, the page must accurately state that person’s role, relevant qualifications, contribution, review date, and any material conflict of interest.

Until a page meets the requirements in our Medical Review Policy, it remains an evidence-cited educational resource rather than medically reviewed content.

The Different Types of Information We Publish

We separate information into distinct categories because each category requires a different verification method.

1. Official and regulatory information

This includes drug approval status, prescribing information, safety communications, recalls, controlled-substance rules, federal regulations, state licensing records, laboratory certification records, and pharmacy registration or licensing information.

The preferred source is the agency, regulator, official database, statute, regulation, or current product labeling responsible for that information.

2. Clinical guidance and scientific evidence

This includes recommendations from professional medical organizations, systematic reviews, randomized trials, observational studies, diagnostic research, safety studies, and clinical-trial records.

The appropriate source depends on the question. A current guideline may be the best source for a clinical recommendation, while a full trial report may be the best source for a specific study result.

3. Provider-published and provider-confirmed information

This includes pricing, membership terms, treatment formats, state availability, clinician-access models, testing requirements, pharmacy relationships, cancellation rules, and support channels.

A provider’s website or written response can establish what the provider publicly represents. It cannot, by itself, prove treatment effectiveness, quality of care, patient outcomes, or compliance in every individual case.

4. Calculated information

This includes first-year cost estimates, monthly equivalents, price ranges, percentages, normalized comparisons, and other figures produced from sourced inputs.

Calculated information is labeled as an estimate or calculation and should include enough information for a reader to understand the formula and assumptions.

5. Consumer-reported information

This includes reviews, complaints, testimonials, forum discussions, and reader submissions.

Consumer reports may reveal recurring operational themes, such as billing confusion, shipping delays, communication problems, or ease of cancellation. They are not clinical evidence and cannot establish whether a treatment is safe, effective, or appropriate.

We do not present one category as another. A testimonial is not a clinical trial. A provider’s marketing statement is not an FDA determination. A calculated estimate is not a quoted price. A current license is not a quality award.

The Best Source Depends on the Question

We do not apply one rigid evidence hierarchy to every type of claim. The most appropriate source depends on what is being verified.

Question	Preferred source	What is not sufficient by itself
Is a drug FDA-approved, and for what use?	Current FDA approval records, prescribing information, safety communications, and current labeling	A clinic page, advertisement, testimonial, search-result snippet, or affiliate brief
What do clinical guidelines recommend?	The current guideline or formal statement from the issuing professional organization	A clinic blog, news summary, isolated quotation, or undated infographic
What did a study find?	The full peer-reviewed paper, supplemented by the trial registration, protocol, or statistical analysis plan when relevant	A headline, abstract alone when full text is available, conference promotion, or company press release
Is a clinician currently licensed?	The applicable state professional licensing board	An NPI record, provider biography, LinkedIn profile, or directory listing
Does a laboratory have a CLIA certificate?	The CMS CLIA database or applicable official record	A clinic’s general statement that it uses a “certified lab”
Is a pharmacy licensed or registered?	Applicable state board records and, where relevant, FDA outsourcing-facility records	A provider’s use of phrases such as “FDA-approved pharmacy”
What does a provider currently charge?	Current pricing pages, checkout disclosures, written terms, enrollment documents, and dated provider confirmation	An old review, search snippet, affiliate commission sheet, or an unexplained “starting at” price
In which states does a provider operate?	Current provider disclosures, clinician-license information when relevant, and direct dated confirmation	A vague “nationwide” marketing statement
What do patients report about the experience?	Multiple recent and independently hosted review or complaint sources, interpreted cautiously	A single positive or negative review, a provider-curated testimonial page, or an unexplained average star score

A source’s official status does not make it infallible or universally applicable. We still check its date, scope, definitions, jurisdiction, population, and current status.

Our Research Process

Step 1: Define the exact claim

Research begins by defining what we are trying to establish.

For example, “this provider is affordable” is too vague to verify. More useful questions include:

What mandatory charges apply during the first 12 months?
Does the advertised price include medication?
Are baseline and follow-up laboratory tests included?
Is the lowest price tied to a particular dose, commitment, promotion, or treatment format?
Does the provider charge separately for consultations, supplies, or shipping?

Medical questions are also narrowed before research. A study involving one testosterone formulation, population, outcome, and duration should not automatically be generalized to every patient or every form of treatment.

Step 2: Locate the most direct source

We look for the original or controlling source before relying on summaries.

Depending on the claim, this may include:

FDA records and current drug labeling
DEA materials
Federal Register notices and federal regulations
State medical, pharmacy, and professional licensing boards
CMS laboratory records
Current professional clinical guidelines
PubMed-indexed studies
ClinicalTrials.gov records
Provider pricing, legal terms, policies, and enrollment disclosures
Direct written confirmation from a provider

Reputable secondary sources may help explain an issue or identify an original source. Material claims should still be traced to the most direct available source whenever practical.

We do not use search-result snippets, automated summaries, social-media posts, or AI-generated answers as primary evidence.

Step 3: Check the source’s status and date

A source may have several relevant dates:

Publication date
Effective date
Last revision date
Labeling revision date
Guideline update or amendment date
Study completion date
Date results were posted
Date we accessed the source

Those dates do not mean the same thing.

When timing is material, we identify the relevant date rather than calling information simply “current.” A source-access date means that the source was checked on that date. It does not guarantee that the source did not change afterward.

Step 4: Capture the claim with its context

For material claims and data points, our working record is designed to capture:

The exact claim or field being researched
Source organization or publisher
Source title and link
Publication, revision, or effective date when available
Date accessed
Relevant section, table, page, or quotation when practical
Population, jurisdiction, treatment, dose, timeframe, and outcome
Unit, denominator, and currency
Whether the information is official, provider-published, provider-confirmed, calculated, consumer-reported, or unresolved
Material limitations or conflicting information

A number without its unit, population, timeframe, and denominator can be more misleading than useful.

Step 5: Cross-check material information

Not every basic fact requires two independent sources. However, we seek additional confirmation when:

The source is incomplete or ambiguous
Two provider pages give different terms
A marketing page conflicts with checkout or legal terms
A secondary source conflicts with an official source
A provider makes an unusually strong medical claim
A price appears to omit mandatory charges
A regulation or guideline has recently changed
A material conclusion depends on a single small study
A source has a direct commercial interest in the claim

When credible sources disagree, we do not silently select whichever answer is more convenient. We examine differences in date, population, definitions, formulation, jurisdiction, and methodology. If the conflict cannot be resolved, we describe it as unresolved.

Step 6: Perform a separate verification pass

Research and drafting are separate steps in our workflow.

Before publication or a material update, important factual claims should be checked again against the underlying source. Calculations should be recomputed from their recorded inputs. Links, dates, units, denominators, and commercial disclosures should also be reviewed.

This verification pass is editorial fact-checking. It is not medical review and does not create a clinician-patient relationship.

Step 7: Publish the limits with the conclusion

We do not remove uncertainty merely to make a page sound decisive.

When information is missing, conflicting, provider-reported, estimated, outdated, or not independently verified, that status should be visible to the reader.

Unknown is a research result. It is not a blank to fill with an assumption.

How We Evaluate Medical Evidence

A citation does not automatically make a medical claim reliable. We consider how closely the evidence supports the exact statement being made.

Directness

We ask whether the evidence involves the same:

Population
Condition
Treatment or formulation
Dose or treatment strategy
Comparator
Outcome
Follow-up period
Care setting

Evidence about one product, formulation, dose, age group, or clinical population may not apply directly to another.

Study design

Different designs answer different questions.

Randomized controlled trials can be useful for estimating treatment effects under defined conditions. Observational studies can identify associations and may provide longer-term or real-world information, but they are generally more vulnerable to confounding. Case reports and adverse-event reports can identify possible safety signals but cannot establish how frequently an event occurs.

Laboratory, animal, and mechanistic studies may help explain a biological possibility. They are not treated as proof of a meaningful benefit or risk in humans.

Size, duration, and completeness

We consider:

Number of participants
Number of events
Length of follow-up
Dropout and missing-data rates
Whether the study was stopped early
Whether the planned outcomes were fully reported
Whether the result came from a prespecified primary outcome, secondary outcome, subgroup, or post hoc analysis

A statistically significant result from a small, short, or exploratory analysis may still be uncertain or clinically unimportant.

Outcome relevance

We distinguish between:

Laboratory or surrogate outcomes
Symptom scores
Patient-reported outcomes
Functional outcomes
Clinical events
Adverse events
Long-term health outcomes

A change in a laboratory value should not automatically be described as proof that a patient will feel better or experience a better long-term outcome.

Absolute and relative effects

When useful data are available, we prefer to provide absolute numbers and denominators rather than relying only on relative percentages.

A large relative change can represent a small absolute difference. Conversely, an average result may hide meaningful variation among individuals.

Consistency

We consider whether findings are consistent across studies and whether apparent differences may be explained by population, dose, formulation, study duration, outcome definitions, or risk of bias.

One study is not described as settling a question when substantial uncertainty or conflicting evidence remains.

Funding and conflicts of interest

Industry funding does not automatically invalidate a study, and noncommercial funding does not automatically make a study reliable.

We consider disclosed funding, author conflicts, sponsor involvement, study design, outcome selection, reporting completeness, and consistency with independent evidence.

Publication status

Peer review is relevant but is not a guarantee that a study is correct.

Preprints, conference abstracts, press releases, and unpublished trial records are clearly identified and are not presented as carrying the same evidentiary weight as a complete peer-reviewed report.

When practical, we check whether an article has been corrected, withdrawn, or retracted. We do not knowingly rely on a retracted article as valid evidence.

Formal evidence grading

Unless a page expressly describes a formal evidence-grading process, our descriptions of evidence strength are editorial summaries rather than official GRADE ratings or formal systematic-review conclusions.

We do not call an article a systematic review merely because it cites multiple studies. A page labeled as a systematic review would require a separately published search strategy, databases searched, date range, inclusion and exclusion criteria, screening method, and evidence-synthesis process.

How Our Language Reflects the Evidence

We use wording intended to show what a source can and cannot establish.

Wording	What it generally means
“FDA-approved”	The approval status was confirmed through an FDA source for the specific product and use being discussed
“Guidelines recommend”	A named, dated guideline contains that recommendation for a defined population or situation
“The study found”	We are describing a result from the cited study, not necessarily a universal clinical conclusion
“Evidence suggests”	Relevant evidence exists, but limitations or uncertainty remain
“May” or “can”	An outcome is possible or variable; it is not guaranteed
“Was associated with”	The evidence demonstrates an association but does not by itself prove causation
“The provider states”	The information comes from the provider and may not have independent confirmation
“Provider-confirmed”	The provider supplied dated written confirmation of the specific fact
“We calculated” or “we estimate”	The figure was produced from disclosed sourced inputs and assumptions
“We could not verify”	We did not find adequate confirmation from the sources reviewed
“Not publicly disclosed”	The information was not located in the provider’s accessible public materials at the time checked
“Unclear”	Available sources were incomplete, ambiguous, or conflicting

We avoid guaranteed-outcome language, unsupported superlatives, and terms such as “clinically proven” when the available evidence does not support that level of certainty.

How We Research TRT Providers

Provider research is a structured review of available evidence. It is not a clinical audit, accreditation, endorsement, or guarantee of care quality.

Depending on the review, we may investigate:

Provider identity and ownership
The organization operating the service, associated brands, available business information, and whether ownership or operational relationships are clearly disclosed.
Clinical eligibility process
How symptoms, medical history, laboratory results, contraindications, treatment goals, and prescribing eligibility are described.
Clinician access
Whether care involves a physician, nurse practitioner, physician assistant, or other licensed professional; whether visits are live or asynchronous; and how patients contact a clinician between scheduled reviews.
Licensure and geography
Public professional-license records, stated service areas, and whether a provider’s “nationwide” language is supported by more specific state information.
Testing requirements
Baseline testing, repeat testing when applicable, testing method, laboratory source, follow-up schedule, and whether the advertised price includes required tests.
Treatment formats
The testosterone and non-testosterone options the provider says it offers, without assuming that every listed option is appropriate or available to every patient.
Medication and pharmacy transparency
Whether the product is FDA-approved or compounded, which pharmacy or dispensing organization is involved, and whether those relationships are disclosed clearly.
Fertility handling
Whether fertility plans are addressed before treatment and whether the provider clearly explains that external testosterone can suppress sperm production.
Monitoring and escalation
How the provider describes follow-up, dose changes, symptom review, adverse-effect management, laboratory monitoring, referrals, urgent concerns, and transfers of care.
Total cost and commitment
Consultation, membership, medication, labs, supplies, shipping, follow-up, minimum terms, renewals, refunds, cancellation, and record-transfer policies.
Patient support
Clinical communication, administrative support, response channels, support hours, refill handling, and complaint pathways.
Claims and disclosures
Outcome promises, “optimization” language, safety claims, treatment limitations, affiliate relationships, testimonials, and other representations that may affect a reader’s decision.

The complete provider-review process is explained in How We Review TRT Providers.

How We Verify Professional, Laboratory, and Pharmacy Information

Clinician records

We may use the National Provider Identifier Registry to help distinguish healthcare professionals and organizations with similar names. An NPI does not establish that a person is currently licensed, credentialed, board-certified, or qualified for a particular service.

Current licensure should be checked through the applicable state licensing authority. A point-in-time license check does not guarantee future status, quality of care, absence of discipline, or suitability for a particular patient.

Laboratory records

When a provider identifies a laboratory, we may review available CMS CLIA records or other applicable official information.

A CLIA certificate is relevant to laboratory status. It does not prove that every test was ordered appropriately, collected under ideal conditions, interpreted correctly, or used within a complete clinical evaluation.

Pharmacy and compounding records

We distinguish among:

FDA-approved drugs
FDA-approved generic drugs
Compounded drugs
State-licensed pharmacies
Section 503A compounding pharmacies
FDA-registered Section 503B outsourcing facilities
Manufacturers, wholesalers, dispensing practices, and other medication-related entities

Compounded drugs are not FDA-approved. Registration of an outsourcing facility does not mean that the facility or every product it produces has been FDA-approved or endorsed.

We do not describe a pharmacy, clinic, or outsourcing facility as “FDA-approved.” FDA does not approve or license pharmacies or outsourcing facilities in that manner.

Pharmacy status may involve both federal and state oversight. Public records can be incomplete, delayed, or difficult to match across related legal and brand names. When a relationship cannot be confirmed, we say so rather than inferring it from a logo or marketing statement.

Our Provider Information Labels

Provider pages may use the following labels or equivalent plain-language descriptions:

Label	Meaning
Official record	Confirmed through an applicable government, regulatory, licensing, or official labeling source
Provider-published	Displayed in the provider’s public website, terms, checkout, policy, or enrollment materials
Provider-confirmed	Supplied to TRT Provider Guide in a dated direct communication
Calculated by TRT Provider Guide	Produced using identified inputs, formulas, and assumptions
Editorial assessment	Our reasoned comparison or interpretation of sourced information
Consumer-reported	Drawn from reviews, complaints, testimonials, forums, or reader reports
Not independently verified	Reported by an interested party without adequate independent confirmation
Not publicly disclosed	Not located in the public materials reviewed
Unresolved	Available sources conflict or do not support a reliable conclusion

“Verified” means that a specific statement was matched to a specified source on a specified date. It does not mean that TRT Provider Guide has certified the provider, treatment, pharmacy, clinician, or patient experience.

Direct Provider Verification

When public information is unclear, we may contact a provider with focused factual questions.

Direct confirmation is labeled with the date and scope of the response. It remains provider-supplied information unless independently supported by another source.

A provider’s response—or lack of response—is handled as follows:

A response may clarify a factual field but does not guarantee how every patient’s care will be handled.
No response is not treated as proof of poor care.
An incomplete response is reported as incomplete rather than filled with assumptions.
Providers may identify factual errors and supply supporting documentation.
Providers do not receive authority to approve our conclusions, ratings, comparisons, or wording.
We do not agree to conceal a material limitation as a condition of receiving information, commercial access, or affiliate compensation.

Where appropriate, a review may state that the provider was contacted, what was asked, when the request was sent, and whether a substantive response was received.

Pricing and Cost Methodology

TRT pricing can be difficult to compare because providers package care differently.

A low advertised monthly number may exclude consultations, laboratory testing, medication, supplies, shipping, follow-up, or mandatory membership charges. A higher advertised number may include more of the complete care path.

For that reason, we do not treat the lowest headline price as the lowest total cost.

Information we look for

Depending on the provider, we may record:

Initial consultation or enrollment fee
Monthly or annual membership
Baseline laboratory testing
Repeat or follow-up laboratory testing
Medication
Injection supplies or application supplies
Shipping and handling
Required clinician follow-up
Refill or administrative charges
Minimum commitment
Automatic renewal
Cancellation notice requirements
Nonrefundable charges
Dose-dependent pricing
State-dependent charges
Currently available promotions

First-year cost formula

When sufficient information is available, an estimated first-year cash cost may be calculated as:

**Required enrollment and consultation fees

required membership fees
required baseline and follow-up laboratory costs
medication costs
required supplies
required shipping
other mandatory charges
− unconditional discounts available in the stated scenario**

An equivalent monthly cost is generally:

Estimated first-year cost ÷ 12

The formula may be adjusted when a provider uses a different billing cycle or minimum commitment. Any material adjustment should be explained.

Our pricing rules

Standard and promotional prices are separated.
A temporary coupon or affiliate promotion is not silently substituted for the standard price. When shown, the promotion’s terms, eligibility, and date checked should be disclosed.
“Starting at” is not treated as a representative final price.
We identify what the entry price includes and what can make the actual cost higher.
Required charges are included when known.
Optional services are not added to the base estimate unless the comparison scenario includes them.
Unknown charges are not entered as zero.
The result is labeled incomplete or estimated when a mandatory component cannot be verified.
Dose-dependent pricing is shown as a range when necessary.
We do not assume that every patient receives the lowest-cost dose or format.
Comparable scenarios use comparable components.
A medication-only price should not be presented as cheaper than an all-inclusive program without explaining the difference.
Insurance coverage is not assumed.
Coverage, prior authorization, deductibles, copayments, and pharmacy benefits vary by plan and individual circumstances.
Taxes and variable local charges are included only when known.
Otherwise, their exclusion is disclosed.
Rounding does not create false precision.
Calculated totals may be rounded for readability, but source figures and assumptions should remain available.
Prices are point-in-time information.
A “price checked” date records when the cited terms were reviewed. The provider may change its prices afterward.

A provider is not described as the “cheapest” unless the comparison uses materially comparable treatment scenarios and all major mandatory charges can be identified.

How We Use Reviews, Complaints, and Testimonials

Patient experiences can provide useful context, but they require careful handling.

Online reviews are self-selected. They may overrepresent unusually positive or negative experiences, may concern different services or time periods, and may not be independently verifiable. Some platforms remove reviews, solicit reviews, combine locations, or use different moderation systems.

We therefore use reviews primarily to identify possible operational themes, including:

Billing clarity
Shipping and refill experiences
Appointment access
Responsiveness
Cancellation difficulties
Unexpected charges
Record-transfer experiences
Consistency between advertised and reported processes

We do not use testimonials or star ratings to establish:

Medical effectiveness
Safety
Correct diagnosis
Appropriate prescribing
Quality of clinical judgment
Causation between treatment and an outcome
How a future patient will respond

A single anecdote is not presented as a general pattern. When we describe a recurring theme, we consider the number, recency, specificity, and consistency of reports, while recognizing that the available sample may not represent all patients.

Material allegations are not repeated as established facts merely because they appear in a review. We seek independent documentation when the allegation affects a provider’s factual profile.

Provider-selected testimonials are identified as provider-selected rather than independent consumer evidence.

Calculators, Tables, and Original Analysis

“Original analysis” means that TRT Provider Guide organized, normalized, or calculated information from identified sources. It does not mean that we conducted original clinical research, treated patients, tested medications, or measured health outcomes.

A calculator or original table should identify, as applicable:

Source inputs
Date range
Inclusion and exclusion rules
Formula
Units
Currency
Denominator
Assumptions
Missing-data treatment
Rounding method
Material limitations
Date last recalculated

We do not:

Represent a convenience sample as nationally representative
Treat missing data as a negative result
Compare raw counts when rates or denominators are required
Present correlation as causation
Combine materially different populations or outcomes without explaining the limitation
Create a pooled medical-effect estimate without a defined synthesis method
Use excessive decimal precision to imply certainty
Change a denominator without making the change clear

Charts should identify their units, date range, source, and relevant denominator. Visual scales should not be manipulated to exaggerate small differences.

Calculators and decision tools on TRT Provider Guide provide general education. They do not diagnose testosterone deficiency, interpret personal laboratory results, select a medication, recommend a dose, or determine whether treatment is appropriate.

Site-traffic, click, conversion, and affiliate-revenue data are not evidence of medical quality and are not used as substitutes for clinical or provider-quality information.

Missing and Conflicting Data

Missing information is not automatically evidence of bad care. It may, however, affect how confidently a provider can be compared.

For example:

A provider may have a reasonable policy that is not published clearly.
A provider may use qualified clinicians while offering little public credential information.
A price may be accurate for one treatment format but incomplete for another.
State availability may change faster than the provider’s public pages.
A licensing database may be delayed or difficult to match to a brand name.

When information cannot be verified, we report the gap.

In a rating, missing information may affect a transparency-related criterion when public or direct disclosure is itself being measured. It is not automatically converted into a finding of unsafe care or clinical failure.

When sources conflict, we consider:

Which source controls the question
Which source is more recent
Whether the sources describe the same service or population
Whether one source contains legal terms and another contains simplified marketing
Whether one figure includes charges omitted from another
Whether a policy differs by state, medication, dose, or membership level

If the conflict remains unresolved, we do not average the answers or select the more favorable version. We label the issue unresolved.

How We Use Software and Automation

TRT Provider Guide may use software-assisted tools to help locate sources, compare page versions, organize research notes, identify possible inconsistencies, perform arithmetic, structure tables, or assist with drafting and editing.

These tools may include search tools, spreadsheets, databases, monitoring tools, calculators, and language-based systems.

Automation does not create evidence.

We do not treat an automated answer, generated citation, summary, or calculation as reliable merely because it appears confident or polished. Material claims must be checked against the underlying source. Calculations must be tied to identified inputs and formulas.

Software can miss qualifications, confuse similarly named organizations, use outdated information, or misread a source. When an automated result conflicts with the original source, the original source controls.

We do not list software as a medical reviewer or use an artificial persona as an author. The visible organization byline identifies TRT Provider Guide as the publisher accountable for the final page.

Editorial Independence and Commercial Relationships

TRT Provider Guide may earn compensation through certain links or commercial relationships. Those relationships are governed by our Affiliate Disclosure.

On this site, independent refers to editorial control. It does not mean that the site can never earn revenue.

Commercial information is handled under the following rules:

Affiliate payout is not a provider-quality criterion.
Commission rate, conversion rate, click volume, and revenue are not evidence of clinical quality.
A provider does not receive a higher score because it has an affiliate program.
A provider without an affiliate program may still be included or rated favorably.
A provider cannot purchase a favorable conclusion, higher rating, hidden limitation, or removal of a supported criticism.
Free access, discounts, samples, sponsorships, or other material benefits must be disclosed when relevant.
Sponsored placement, if offered, must be identified and visually distinguishable from an editorial rating.
Provider or affiliate materials may be used to identify questions or locate terms, but they do not override official records, current legal terms, or stronger evidence.
Where a commercial relationship conflicts with accurate disclosure of a material fact, the factual disclosure takes priority.

Providers may submit corrections and supporting documentation. Payment is not required for a factual correction, and compensation does not guarantee that a requested change will be accepted.

Update and Freshness Policy

Different information changes at different speeds. We use both scheduled and event-driven reviews.

Our current review targets are:

Information type	Review target
FDA safety communications, recalls, major label changes, and material regulatory developments	Event-driven review after a relevant change is identified and verified
Core medical guides and clinical-evidence summaries	At least every 12 months, or earlier when a material guideline or evidence change is identified
Active provider pricing, membership terms, state availability, and cancellation terms	At least every 90 days on actively maintained rankings and comparisons
Clinician, laboratory, and pharmacy status used in an active provider review	At initial publication, during material review updates, and at least every 6 months when the field remains rating-relevant
Methodology, disclosure, corrections, and other foundational trust pages	At least annually or when the underlying policy changes

These are review targets rather than guarantees that an external fact cannot change between checks.

If a scheduled review is overdue, the previous date remains visible. We do not automatically change a “last updated,” “research updated,” or “price checked” date merely to make a page appear fresh.

What our date labels mean

Published: The page first became publicly available.

Last updated: Material content, analysis, sources, calculations, or policy language was reviewed and changed.

Medical evidence reviewed: The medical evidence and guideline sources relevant to the page were substantively rechecked.

Provider information checked: The identified provider facts were checked on the stated date.

Price checked: The cited price source and included components were reviewed on the stated date.

A new date does not mean that every sentence or every linked source changed. Where practical, field-specific dates are used for volatile information.

Corrections and Material Changes

We aim to correct material factual errors clearly after they are identified and verified.

A material correction may involve:

An incorrect price or required fee
A misidentified clinician, pharmacy, laboratory, or legal entity
An incorrect approval, licensing, or regulatory statement
A calculation error
An inaccurate description of a study or guideline
A provider term attributed to the wrong service
A conclusion that changes after a source is corrected, withdrawn, or retracted
A missing commercial disclosure that could affect how readers interpret the page

Material corrections may receive a dated correction note and entry in our Corrections Policy and Log.

Minor spelling, formatting, grammar, link, or clarity changes may be corrected without a formal log when they do not alter the page’s meaning.

A fact that was accurate when checked but later changed is generally handled as an update rather than an error. If the original page inaccurately described the fact at the time, it is handled as a correction.

Readers and providers may report a potential error through our contact page. A useful correction request identifies:

The page URL
The exact statement or data point
Why it may be incorrect
A current source or supporting document
The date the source was accessed

Please do not send personal symptoms, laboratory results, prescription information, medical records, government identifiers, or other sensitive health information through an editorial correction request.

Important Limits of Our Research

Our research can improve transparency, but it cannot eliminate every limitation.

TRT Provider Guide does not:

Diagnose testosterone deficiency
Interpret an individual’s laboratory results
Determine whether someone should start, continue, change, or stop treatment
Recommend an individual medication or dose
Establish a clinician-patient relationship
Replace a physician, pharmacist, attorney, regulator, insurer, or other qualified professional
Audit private clinical records
Inspect provider offices, laboratories, pharmacies, or manufacturing facilities unless a page explicitly documents such an inspection
Observe every patient interaction
Verify every review or testimonial
Guarantee that a provider follows its published process in every case
Guarantee current licensure, pricing, availability, or regulatory status after the displayed check date
Guarantee that public records are complete or error-free
Certify that a provider is safe, effective, ethical, or appropriate for a particular person
Conduct a formal systematic review unless the page expressly publishes the required methodology
Treat absence of a public complaint, warning, or enforcement action as proof that no problem exists

Provider inclusion is not an endorsement. Provider omission is not a finding of poor quality. A favorable rating is not a medical referral or promise of outcome.

The purpose of our research is to help readers understand the evidence, compare care models, identify hidden tradeoffs, and ask more informed questions before making a consequential healthcare decision.

The promise we make: We will distinguish what we found, where it came from, what we calculated, what we could not verify, and when the information was checked.

The limit we make clear: Public research cannot determine whether a provider or treatment is appropriate for an individual reader.

Methodology Change Log

Date	Version	Change
September 1, 2026	1.0	Initial publication of the Research and Data Methodology

Future material changes to this methodology will be dated and summarized here. Minor formatting or clarity edits that do not change the policy may not receive a separate version entry.

Core Sources and Research Repositories

The following are examples of primary and authoritative resources used in our research process. Not every source applies to every page, and inclusion here does not mean that the source endorses TRT Provider Guide.

Source links checked: September 1, 2026.

Related Trust and Methodology Pages

Medical and Editorial Disclaimer

TRT Provider Guide publishes general educational and comparison information for adults in the United States. We are not a medical practice, telehealth clinic, laboratory, pharmacy, drug manufacturer, insurance company, or government agency.

Nothing on this page is medical advice, diagnosis, treatment, legal advice, insurance advice, or a substitute for evaluation by an appropriately qualified professional. Do not start, stop, or change testosterone or any other prescription medication based on this website.

Medical evidence, product labeling, laws, regulations, provider terms, prices, clinician availability, pharmacy relationships, and service areas may change. Review current official sources and confirm consequential information directly with the relevant provider and qualified professional.

For a medical emergency, call 911 or seek immediate medical care.